Long-term sustained release of ganciclovir from biodegradable scleral implant for the treatment of cytomegalovirus retinitis
Authors:
- Noriyuki KunouNKNoriyuki Kunou
- Yuichiro OguraYOYuichiro Ogura
- Tsutomu YasukawaTYTsutomu Yasukawa
- Hideya KimuraHKHideya Kimura
- Hideki MiyamotoHMHideki Miyamoto
- Yoshihito HondaYHYoshihito Honda
- Yoshito IkadaYIYoshito Ikada
- 1 August 2000
- journal article
- Published by Elsevier in Journal of Controlled Release
- Vol. 68 (2) , 263-271
Abstract
No abstract availableKeywords
This publication has 38 references indexed in Scilit:
- Cytomegalovirus retinitis after the initiation of highly active antiretroviral therapy: a 2 year prospective studyBritish Journal of Ophthalmology, 1999
- Control of the biodegradation rate of poly (dl-lactide) microparticles intended as chemoembolization materialsJournal of Controlled Release, 1996
- Controlled intraocular delivery of ganciclovir with use of biodegradable scleral implant in rabbitsJournal of Controlled Release, 1995
- Kinetics of diffusion-mediated drug release enhanced by matrix degradationJournal of Controlled Release, 1995
- The influence of biodegradable microcapsule formulations on the controlled release of a proteinJournal of Controlled Release, 1994
- The acceleration of degradation-controlled drug delivery from polyester microspheresJournal of Controlled Release, 1989
- Biodegradable microcapsules: Acceleration of polymeric excipient hydrolytic rate by incorporation of a basic medicamentJournal of Controlled Release, 1986
- Control of release rate of bleomycin from polylactic acid microspheres by additives.Chemical and Pharmaceutical Bulletin, 1985
- Aliphatic polyesters II. The degradation of poly (DL-lactide), poly (ε-caprolactone), and their copolymers in vivoBiomaterials, 1981
- Rate of Release of Medicaments from Ointment Bases Containing Drugs in SuspensionJournal of Pharmaceutical Sciences, 1961